Prediction of changes in chemical form of urolithiasis


Cite item

Full Text

Abstract

The course of recurrent urolithiasis was studied in 131 patients (64 females, 67 males, age 27-69 years). Before the start of 1-15-year follow-up the patients' condition was: after spontaneous elimination of the concrements, after extracorporeal shock-wave lithotripsy and/or percutaneous nephrolitholapaxy, after open surgical interventions, after surgery and spontaneous elimination of the concriments, after litholysis (patients with hyperuricemic urolithiasis). At the start of the follow-up 127 patients had no uroliths, 4 patients had bilateral concrements. The group of patients free of uroliths consisted of 33 patients with hyperuricemic urolithiasis, 52 - with calcium-oxalate, 42 - with magnesium-ammonium-phosphate form of the disease. As shown by follow-up ultrasound and x-ray examinations, each of these patients had 1 to 7 recurrent concrements. Infrared spectrophotometry and x-ray diffraction determined chemical composition of both primary and 352 recurrent concrements. The patients were also examined with biochemical, microbiological methods, urine clinical examination was made. Possibility, metabolic and microbiological evidence for changes in urolithogenesis type in patients with different forms of the disease were found. In hyperuricemic urolithiasis recurrent concrements can be calcium-oxalate and phosphate, in calcium-oxalate urolithiasis - phosphate. Transformation of magnesium-ammonium-phosphate urolithiasis into hyperuricemic or calcium-oxalate urolithiasis was observed. Changes in the form of the disease more frequently occur in hyperuricemic and calcium-oxalate urolithiasis than in phosphate one. Phosphate concrements form less frequently in patients with hyperuricemic urolithiasis. One kidney can simultaneously contain hyperuricemic or calcium-oxalate concrement while the contralateral kidney - phosphate concrement associated with uric urease producing infection.

References

  1. Аляев Ю. Г., Кузьмичева Г. М., Колесникова М. О. и др. Клиническое значение физико-химического исследования состава мочевых камней и мочи. Урология 2009; 1: 8-12.
  2. Marangella M. A nephrologist's tasks in nephrolithiasis. G. Ital. Nefrol. 2005; 22 (1): 16-27.
  3. Лопаткин Н. А., Мартов А. Г. (ред.). Избранные лекции по урологии. М.: Литтерра; 2008.
  4. Тиктинский О. Л., Александров В. П. Мочекаменная болезнь. СПб.; 2000.
  5. Spivacow F. R., del Valle E. E., Zancheta J. R. Renal lithiasis. Biochemical changes in the follow-up. Medicina (B. Aires) 2006; 66 (3): 201-205.
  6. Tiselius H. G. Patients' attitudes on how to deal with the risk of future stone recurrences. Urol. Res. 2006; 34 (4): 255-260.
  7. Zilberman D. E., Preminger G. M. Long-term results of percutaneous nephrolithotomy: does prophylactic medical stone management make a difference? J. Endourol. 2009; 23 (10): 1773-1776.
  8. Лопаткин Н. А., Мартов А. Г. (ред.). Избранные лекции по урологии. М.: Литтерра; 2008.
  9. Колпаков И. С. Мочекаменная болезнь: Учеб. пособие для врачей. М.: Академия; 2006.
  10. Pasch A. Metaphylaxis of recurrent renal calcium stones. Ther. Umsch. 2007; 64 (5): 253-258.
  11. Unal D., Yeni E., Verit A., Karatas O. F. Prognostic factors effecting on recurrence of urinary stone disease: a multivariate analysis of everyday patient parameters. Int. Urol. Nephrol. 2005; 37 (3): 447-452.
  12. Sutton R. A. The use of risk indices: do they predict recurrence? Urol. Res. 2006; 34 (2): 122-125.
  13. Афифи А., Эйзен С. Статистический анализ. Подход с использованием ЭВМ. М.; 1982.
  14. Гублер Е. В. Вычислительные методы анализа и распознавания патологических процессов. М.: Медицина; 1978.
  15. Константинова О. В., Яненко Э. К., Дзеранов Н. К. Метаболические различия нерецидивного и рецидивного уролитиаза. Урология 1999; 5: 8-9.
  16. Miano R., Germani S., Vespasiani G. Stones and urinary tract infections. Urolo. Int. 2007; 79 (Suppl. 1): 32-36.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies